##
|ABOUT BREAST CANCER UK|ABOUT BREAST CANCER UK|2-6|
|---|---|---|
|Our charitable
objectives||3|
|Our guiding
principles
Impact Report / A word from the Chair and CEO||3
4-5|
|Working towards
our strategic goals||6|
|TRUSTEE REPORT:OUR ACTIVITIES AND||7-14|
|ACHIEVEMENTS|||
|Research projects
Grant programme||8-10
11-14|
|OUR EDUCATION
PROGRAMME||15-18|
|Prevention
advice||15|
|Prevention
Week||16|
|BCAM||17|
|Plans for our education
programme||18|
|OUR GENEROUS SUPPORTERS
Our donors and fundraisers||19-21
19|
|Philanthropy,
corporate partners
and|legacies|21|
|OUR ADVOCACY PROGRAMME||22-24|
|Advocacy and campaigning
Plans for our advocacy and public affairs programme||22
24|
|FINANCIAL
REVIEW||25-28|
|STRUCTURE GOVERNANCE|AND|28-30|
|MANAGEMENT|||
|Structure||28|
|Governance||29|
|Staff||29-30|
|Risk Management||30|
|Statement of Public Benefit||30|
|ANNUAL
REPORT AND FINANCIAL||31-48|
|STATEMENTS|||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
#
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|---|
||||funds|t'unde||funds|funds||
||||2023|2023|2023|2022|2022|2022|
|||Notes|||||||
|Income from:|||||||||
|Oonations
and|||||||||
|legacies||3|$,433,844|137,44f|1,571,285|857,451|70,144|927,595|
|Charitable
activities||4|83|-|83||||
|investmenh||5|14,471||14,471|2,279||2,279|
|Total income|||1,448,398|$37,44f|1,585,839|859,730|70,144|929,874|
|Ex
nditure on:|||||||||
|Raising funds|||205,476||205,476|'i44,175||144,175|
|Charitable
activities|||||||||
|Campaign
costs|||141,996|22,550|164,546|84,838||84,838|
|Education cosh|||185,993|18,480|204,473|133,601|18,159|151,760|
|Science msts|||137,235|-|137,235|321,778||321,778|
|Total charitable|||||||||
|expenditure|||465,224|41,030|506,254|540,217|'i8,159|558,376|
|Total expenditure|||670,700|41,030|711,730|684,392|18,159|702,551|
|Net incoming resources|||||||||
|before transfers|||777,698|96,41f|874,109|175,338|51,985|227,323|
|Gross transfers|||||||||
|behveen
funds|||2,994|(2,994)||(24,096)|24,096||
|Net income for|the year/||||||||
|Net movement|in funds||780,692|93,417|874,109|151,242|76,081|227,323|
|Fund balances at 1||April|||||||
|2022|||821,152|57,972|879,124|669,910|(18,109)|651,801|
|Fund balances|at|31|||||||
|March 2023|||1,601,844|151,389|1,753,233|821,152|57,972|879,124|
##
##
|||||2023|2022||
|---|---|---|---|---|---|---|
||||kotes||||
|Current assets|||||||
|Oebtors|||12|38,746|13,372||
|Cash atbank and inhand||||1,932,025|1,147,590||
|||||1,970,771|1,160,962||
|Creditors:|amounts|falling due within|||||
|one year|||13|(109,110)|(140,319)||
|Net current|assets|||1,861,661||1,020,643|
|Creditors:|amounts|falling due after|||||
|more than|one year||14|(108,428)||(141,519)|
|ket assets||||1,753,233||879,124|
|Income funds|||||||
|Restricted|funds||17|151,389||57,972|
|Unrestricted|funds||||||
|l3esigriated|funds||18|444,000|225,000||
|General
unrestricted||funds||1,157,844|596,152||
|||||1,601,844||821,152|
|||||1,753,233||879,124|
|||||2II23|||2022||
|---|---|---|---|---|---|---|---|---|
|||Notes|||||||
|Cash flows from operating|activities||||||||
|Cash generated
from operations|||||769,964|||419,762|
|Investing activities|||||||||
|Investment
income received|||14,471|||2,279|||
|Net cash generated
I'rom investing|||||||||
|acttvtt les|||||14,471|||2,279|
|Net cash used in financing|activities||||||||
|Net increase in cash and cash equivalents|||||784,435|||422,041|
|Cash and cash equivalents|at beginning|ofyear|||1,147,590|||725,549|
|Cash and cash equivalents|at end of|year|||1,932,025|||1,147,590|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||||2023|2022|
|---|---|---|---|---|---|---|---|
|||||||K||
||Ticket sales|||||83||
|5|Investments|||||||
|||||||Unrestricted|Unrestricted|
|||||||funds|funds|
|||||||2023|2022|
|||||||K|E|
||Deposit account irrlerest|||||14,47'I|2,279|
|6|Raising funds|||||||
|||||||Unrestricted|Unrestricted|
|||||||funds|funds|
|||||||2023|2022|
|||||||E|K|
||Raisin
donations||and||acies|||
||consultancy|fees||||600|26,050|
||Subscriptions|||||2,286|1,862|
||Telephone||||||497|
||Printing,
postage||and|stationery||2,162|1,953|
||Promotional|activities||||20,660|21,929|
||Sundries|||||5,360|5,529|
||Staff costs|||||109,442|62,315|
||Donor entry|and platform|||fees|'l9,191|24,040|
||Total|||||159,691|144,175|
||Share of support||costs (see note 8)|||42,021||
||Share ofgovernance|||costs (see note 8)||3,764||
|||||||205,476|144,175|
##
||||Campaign|Education|Science|Total|Campaign|Education|Science|Total|
|---|---|---|---|---|---|---|---|---|---|---|
||||costs|costs|costs|2023|costa|costa|coals|2022|
||||2023|2023|2023||2022|2022|2022||
|||||9|9||||||
|Sla6'casts|||82,415|104,867||271,314|82,498|74,717|89,824|1,96,637|
|Consultancy|fees||596|16,781||t7,977|2,674|15,423|2,073|20,170|
|ITsoftware snd||support costs|||||560|1.112|355|2,057|
|Pramalicnal
Subscriptions|activities||2,524
9.211|3PI85
1,074|2,780|9/89
t0,255|1,497
5~|5,905
544|1/59
437|8/St
6/24|
|Training costs|||119|938||1,319|166||336|504|
|Research aosts|||||||||4,994|4,994|
|Grants|||||1,039|1,039|||205,452|205,452|
|Recrullrrlnt|costs||2,782||1,063|3,835|||702|1,244|
|Peerage and|SWionsry||||5|5|||13|13|
|Telephone|||||||270|251|4%|987|
|Prevenfion
hub|||2,487|728||4,055||31,825||31,825|
|f0ck Start a|Chernicah||22,550|||22,550|||||
|Breast Cancer in Men||||t8,460||18,450|||||
||||122,664|146,851|90,633|360,148|72,926|130,319|275,721|478,966|
|Share ofsupport||costs (see note 8)|38,119|53/58|42/38|134@5|11302|20,349|43,709|75,360|
|Share ofgovernance coals (see note 8)|||3,763|3,784|3,784|11,291|608|1,092|2,348|4,048|
||||164,545|204,473|137235|505254|84538|151,780|321,7T8|555,378|
|Analysis
by|fund||||||||||
|Unreslricted|funds||141,996|185,993|137,235|465224|84,838|133,601|321,7T8|540,217|
|Rsstncted funds|||22,550|18,480||41,030||18,'l 59|-|18,'!59|
|Charitable||activities||||||||(Continued)|
||||164,646|204,473|t37/36|5D6/84|$4,838|151,760|321,778|558,$76|
|8|Support costs||Support|Governance|2023|Support|Governance|2022|
|---|---|---|---|---|---|---|---|---|
||||costs|costs||costs|costs||
||Staff costs||81,939||81,939|56,192||56,192|
||Staff training,
welfare and||||||||
||recruitment||9,798||9,798|1,557||1,567|
||Postage and stationery||724||724|606||606|
||Travel, accommodation||||||||
||and meetings||7,351||7,351|852||852|
||insurance
costs||2,066||2,066|1,784||1,784|
||Website and ITcosts||58,946||58,946|6,931||6,931|
||Sundries||2,712||2,712|1,463||1,463|
||Telephone||3,768||3,768|791||791|
||Subscrtptions
snd||||||||
||memberships||3,634||3,634|1,921||1,921|
||Consuttancy fees||5,768||5,788|3,253||3,253|
||Finance costs||110||110|'l0||10|
||Audit Fees|||6,600|6,600||||
||Accountancy
Fees|||5,354|5,354||3,420|3,420|
||Legal and professional||||||||
||fees|||2,213|2.213|||460|
||Trusses'
meetings|and|||||||
||training|||888|888||168|168|
||||176,836|15,055|19'I,891|75,360|4,048|79,408|
||Anafysed
between:||||||||
||Cost ofRaising Funds||42,021|3,764|45,785||||
||Charitable
activities||134,815|11,29'I|146,106|75,360|4,048|79,408|
||||176,836|15,055|191,891|75,360||79,408|
##
##
|The average|monthly
num|ber ofemploye|es
during the|year was:|||
|---|---|---|---|---|---|---|
||||||2023|2N2|
||||||Number|Number|
|Management|and administration||||||
|Fundraistng|||||||
|Campaigns,|Science and|Education|||||
|Total|||||||
|Employment|costs||||2023|2N2|
|Wages and salaries|||||419,754|292,377|
|Social security costs|||||29,517|15,989|
|Other pension costs|||||13,424|6,978|
||||||462,695|316,344|
|The number|ofemployees|whose annual|remuneration|was more than 260,000|||
|isas follows:|||||||
||||||2023|2922|
||||||Number|Number|
|f70,0G'l - EM,OOG|||||||
##
##
|Debtors||||
|---|---|---|---|
|||2023|2022|
|Amounts
falling due within one year:||||
|Monies owed||12,183|514|
|Other debtors||24,889|'l1,184|
|Prepayments|and accrued incame|1,674|1,674|
|||38,746|13,372|
##
|13|Creditors: amou|nts||falling|due within on|e year|||||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||2023|2022|
||Other taxation and social security|||||||||1,559|
||Trade creditors||||||||15,414|4,191|
||Grants payable||||||||83,769|122,944|
||Accruals and deferred|||income|||||9,927|t1,625|
||||||||||109,1'l 0|140,319|
|14|Creditors: amounts|||falling|due after more than one||year||||
||||||||||2023|2022|
|||||||||Notes||E|
||Deferred grants||||||||108,428|141,519|
|15|Deterred income||||||||||
||||||||||2023|2022|
|||||||||||R|
||Deferred grants||||||||108,428|141,519|
||Deferred inmme|isincluded|||in the financial|statements|as follows:||||
||||||||||2023|2022|
||||||||||R||
||Deferred income|is included|||within;||||||
||Non~rrent
liabiliTies||||||||'f08,428|141,519|
||Movemente
in the year:||||||||||
||Deferred income|at 1||April 2022|||||$41,519|8,672|
||Released from previous periods||||||||(33,091)|(8,672)|
||Resouices deferred||in the year|||||||141,519|
||Deferred income|at 31 March|||2023||||$08,428|141,519|
##
##
|17|Restricted funds|Restricted funds|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||The income funds ofthe charity include||restricted||tunds oompnsing||the forewing|unexpended|||balances||ofdonalions
and grards held on trust for|||specilio purposes;|
||||||||frfcntentent|in|fttnds|||||Nlcntentent
in htrtth|||
||||||uetenee it|tneew lie
tteeowsin|||||||aelinee ~t
lncewllle||tteeoltwee|Tlitlefile
Selenee et|
|||||1|April 202'l|wiowcex
expended|||||||1ApN|2S22
wiowcei|expended|S'l March 2022|
|||||||||||||||6|6|6
6|
||Breast Density Reseatoh Project||||(4,746)||7,740||||||2,994|||(2,994)|
||Oxrsfarots Proptct
Creation and dtnattopment
ofDLT
Young pecqje educatonal
resource||||(24,608)
11~||512
7,000
fT,570
(18,159)||||24,096||86
fT,570
30,0X|||(66)
4T,570|
||Breast cancer In men resource
Biephenols research project
Chemicals~t||||||17,570
19,752||||||17,670
19,752
2@91
50
25,DX||(16,450)
(22,550)|56
1,587
19,802
2,450|
||General science research|||||||||||||80,000||80,900|
||||||(18,1D9)||70,144
(18,159)||||24,D96|||f37,441|(41,030)|(2 tt94)
151,$59|
|18|Oesignated
funds||||||||||||||||
||The income funds|of the|charity||include|the following|||designated|||funds||which
have|been set|aside out of|
||unrestricted
funds by the trustees||||for spedfic purposes.||||||||||||
||||||||||||||Movement
in||funds||
|||||Bstjanca ftt|||Transfers||Mama stt|||||Incofnlrtg|Rasattrcas|BfstttntMt
ttt|
||||1|Aprtt 2(I21|||||1|April 2022||||resources|expended|N Njareh 202$|
||Science Grant Budget||||100,000||100,000|||200,000||||220000||420,000|
||CRM Development||||||25,000||||25,000||||(25,000)||
||Conversion
ofOnline
Quiz|||||||||||||10,000||10,000|
||HRT Scientific brief|||||||||||||9,000||9,000|
||Breast Feeding resource|||||||||||||5,000||5,000|
||||||100,000||125,000|||225,000||||244,000|(25,000)
444,000||
|19|Analysis of net assets between||||funds||||||||||||
||||Unresbicled|||Restricted|||||Total|Unrestricted
Restricted||||Total|
||||||funds||funds|||||||funds|ftj(nds||
||||||2023||2023||||2023|||2022|2022|2022|
||||||||||||K|||K|||
||Fund balances at 31||||||||||||||||
||March 2023 are||||||||||||||||
||represented
by:||||||||||||||||
||Current assets/(liabilities)||1,677,'i82||||184,479||1,861,661|||||896,490|f24,153|1,020,643|
||Long term liabiliTies|||(75,338)|||(33,090)||(108,428)|||||(75,338)|(66,18'I)|(141,519)|
||||'t,601,844||||'I51,389||1,753333|||||821,152|57,972|879,124|
|Cash generated
from operations|Cash generated
from operations|2023|2022|
|---|---|---|---|
|||K||
|Surplus for the year||874,109|227,323|
|Adjustments
for.||||
|Investment
income recognised|in statement offinancial activities|($4,471)|(2,279)|
|Movements
in wo(fdng capital-.||||
|(increase) in debtors||('i3,364)|(13,372)|
|(Decrease)/increase
in creditors||(31,209)|140,319|
|(Decrease)jtncrease
in deferred|income|(33,091)|141,519|
|Cash generated
from operatio|ns|781,974|517,550|
##